X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (7) 7
disease (4) 4
drugs (4) 4
orphan drugs (4) 4
rare diseases (4) 4
access (3) 3
collaboration (3) 3
drug approval (3) 3
europe (3) 3
european union (3) 3
genetics & heredity (3) 3
marketing (3) 3
orphan drug production (3) 3
rare diseases - drug therapy (3) 3
research (3) 3
analysis (2) 2
care (2) 2
clinical trials (2) 2
consortia (2) 2
decision making (2) 2
designation (2) 2
drug evaluation (2) 2
fda approval (2) 2
funding (2) 2
health technology-assessment (2) 2
laws, regulations and rules (2) 2
medicine (2) 2
medicine, general & internal (2) 2
medicine, research & experimental (2) 2
orphan drug production - economics (2) 2
orphan drug production - legislation & jurisprudence (2) 2
orphan medicinal products (2) 2
pharmaceutical industry (2) 2
rare diseases - therapy (2) 2
reimbursement (2) 2
research & development--r&d (2) 2
studies (2) 2
united states (2) 2
1506 (1) 1
1723 (1) 1
[ sdv ] life sciences [q-bio] (1) 1
abridged index medicus (1) 1
access to information (1) 1
anticancer drugs (1) 1
approval (1) 1
approvals (1) 1
article (1) 1
biochemistry & molecular biology (1) 1
biomarkers (1) 1
biotechnology (1) 1
biotechnology & applied microbiology (1) 1
cancer drugs (1) 1
cancer therapies (1) 1
challenges (1) 1
chronic diseases (1) 1
clinical trials as topic (1) 1
clinical-trials (1) 1
clinicaltrials.gov (1) 1
complement (1) 1
conduct (1) 1
conferences (1) 1
consistency (1) 1
cost control (1) 1
costs (1) 1
data bases (1) 1
decision analysis (1) 1
decision support techniques (1) 1
decision-making (1) 1
deficiency (1) 1
design (1) 1
designación (1) 1
development failure (1) 1
dosage and administration (1) 1
drug costs (1) 1
drug design (1) 1
drug development (1) 1
drug evaluation, preclinical (1) 1
enfermedad rara (1) 1
environmental impact (1) 1
ethical standards (1) 1
ethics (1) 1
european medicines agency (1) 1
evaluation (1) 1
evidem (1) 1
evidem framework (1) 1
failure (1) 1
feasibility analysis (1) 1
federal regulation (1) 1
finance (1) 1
framework (1) 1
general works (1) 1
genetics (1) 1
government regulation (1) 1
guidelines (1) 1
guidelines as topic (1) 1
health care (1) 1
health care sciences & services (1) 1
health policy (1) 1
health services needs and demand (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9629, pp. 2041 - 2044
Journal Article
Arbor, ISSN 0210-1963, 11/2018, Volume 194, Issue 789, p. 466
Journal Article
Arbor, ISSN 0210-1963, 07/2018, Volume 194, Issue 789
Orphan drugs are intended for the treatment of diseases of low prevalence, also known as rare diseases. Research and development into new therapies for this... 
Investigation | Designation | Incentives | Orphan drug | Rare disease | medicamento huérfano | designación | incentivos | investigación | Enfermedad rara
Journal Article
Journal Article
Journal Article
Pharmaceuticals Policy and Law, ISSN 1389-2827, 2001, Volume 3, pp. 19 - 30
Journal Article
Anales del Sistema Sanitario de Navarra, ISSN 1137-6627, 05/2007, Volume 30, Issue 2, pp. 177 - 190
El concepto de Enfermedades Raras es relativamente nuevo. Suponen aquellos procesos "que pueden ser mortales o provocar un debilitamiento crónico del paciente... 
Chronic diseases | Orphan drugs | Rare Diseases | Quality of life | Sociosanitary model
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.